✦ LIBER ✦

Survival analysis of an additional therapy with oral enzymes in patients with multiple myeloma

✍ Scribed by Sakalova, A.; Dedik, L.; Bock, P.R.; Hanisch, J.; Schiess, W.

Book ID: 123557771
Publisher: Elsevier Science
Year: 1999
Tongue: English
Weight: 116 KB
Volume: 35
Category: Article
ISSN: 0959-8049
DOI: 10.1016/S0959-8049(99)81755-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Retrolective cohort study of an additive

Retrolective cohort study of an additive therapy with an oral enzyme preparation in patients with multiple myeloma

✍ Adriena Sakalová; Paul R. Bock; Ladislav Dedík; Jürgen Hanisch; Wilfried Schiess 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 161 KB

Prolonged survival after intensive thera

Prolonged survival after intensive therapy and purged ABMT in patients with multiple myeloma

✍ Reece, D E; Brockington, D A; Phillips, G L; Barnett, M J; Klingemann, H-G; Nant 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 70 KB

Impact of complete remission with intens

Impact of complete remission with intensive therapy in patients with responsive multiple myeloma

✍ Alexanian, R; Weber, D; Giralt, S; Dimopoulos, M; Delasalle, K; Smith, T; Champl 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 77 KB

Histomorphometric effect of six month tr

Histomorphometric effect of six month treatment with oral risedronate in patients with multiple myeloma

✍ Cohen-Solal, M.E.; Roux, C.H.; Valentin-Opran, A.; Dougados, M.; Amor, B.; De Ve 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 348 KB

Histomorphometric effect of six month tr

Histomorphometric effect of six month treatment with oral risedronate in patients with multiple myeloma

✍ Cohen-Solal, M.E.; Roux, Ch.; Valentin-Opran, A.; Dougados, M.; Amor, B.; de Ver 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 149 KB

Renal function in the elimination of ora

Renal function in the elimination of oral melphalan in patients with multiple myeloma

✍ C. G. Adair; J. M. Bridges; Z. R. Desai 📂 Article 📅 1986 🏛 Springer 🌐 English ⚖ 329 KB

Pharmacokinetic studies in 11 patients with multiple myeloma were undertaken on the first and last days of one course of chemotherapy. The drug was administered PO in single doses of 6-14 mg daily. Melphalan concentrations were determined by high-performance liquid chromatography. The interpatient v